SCHEMBL15567162

SCHEMBL15567162

O=[N+]([O-])c1cccc(-c2nc3ccccc3n2Cc2ccccc2)c1

nearest known ligand 0.74

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CFTR P13569 11/20 0.74
TP53 P04637 3/20 0.67
ALDH1A1 P00352 3/20 0.65
PDE6D O43924 1/20 0.65
ALDH2 P05091 1/20 0.65
ALDH3A1 P30838 1/20 0.65
MAPT P10636 2/20 0.62
HPGD P15428 2/20 0.60
KMT2A Q03164 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
KDM4E B2RXH2 1/20 0.60
LMNA P02545 1/20 0.60
GAA P10253 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29412012 1.00 CFTR (0.74) CFTRTP53ALDH1A1PDE6DALDH2
SCHEMBL28478230 0.89 CFTR (0.63) CFTRTP53ALDH1A1MAPTHPGD
SCHEMBL29412099 0.89 CFTR (0.63) CFTRTP53ALDH1A1MAPTHPGD
SCHEMBL15569406 0.86 CFTR (0.72) CFTRTP53ALDH1A1PDE6DALDH2
SCHEMBL29412087 0.86 CFTR (0.72) CFTRTP53ALDH1A1PDE6DALDH2
SCHEMBL19032793 0.85 CFTR (1.00) CFTR
SCHEMBL28377078 0.83 CFTR (0.67) CFTRTP53ALDH1A1PDE6DALDH2
SCHEMBL7392247 0.81 MAPT (0.56) CFTRTP53ALDH1A1PDE6DALDH2
SCHEMBL29412044 0.81 TP53 (1.00) TP53ALDH1A1PDE6DALDH2ALDH3A1
SCHEMBL29412022 0.81 CFTR (0.56) CFTRTP53ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 WO claimed
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 WO disclosed